Back to Search
Start Over
Ruxolitinib is more effective than other JAK Inhibitors to treat VEXAS Syndrome: a retrospective multi center study
- Source :
- Blood; 20240101, Issue: Preprints
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 00064971 and 15280020
- Issue :
- Preprints
- Database :
- Supplemental Index
- Journal :
- Blood
- Publication Type :
- Periodical
- Accession number :
- ejs59757595
- Full Text :
- https://doi.org/10.1182/blood.2022016642